Adakveo Savings Programs: What You Need To Know

Last Updated on June 19, 2025

Adakveo is a critical treatment for individuals living with sickle cell disease. But like many specialty medications, the cost of Adakveo can be overwhelming. Insurance limitations, out-of-pocket expenses, and eligibility requirements can make access confusing and difficult.

NeedyMeds is here to simplify your options. We connect individuals to trusted programs that help lower the cost of medications like Adakveo, regardless of insurance status.

In this blog, we’ll guide you through manufacturer savings programs and other ways to reduce the cost of Adakveo. If you’re searching for Adakveo coupons or other assistance programs, you’re in the right place.

What Is Adakveo?

Adakveo (crizanlizumab-tmca) is a prescription infusion treatment used to reduce the frequency of vaso-occlusive crises (VOCs) in people with sickle cell disease (SCD) aged 16 and older. VOCs, also known as pain crises, occur when sickled red blood cells block blood flow, leading to severe pain and complications.

The drug works by targeting P-selectin, a molecule involved in the clumping of blood cells. By blocking this molecule, Adakveo helps reduce cell adhesion and inflammation that contribute to VOCs.

It’s typically administered once per month after two initial loading doses. Like many biologic infusions for rare conditions, it comes with a high price tag, making cost-saving programs essential for many patients.

Why Is Adakveo So Expensive?

Adakveo is a biologic medication, which means it is produced using living cells in a complex and costly manufacturing process. This is one reason it can be expensive.

Currently, there are no approved biosimilars for Adakveo, and insurance coverage can vary. Fortunately, Novartis, the drug’s manufacturer, offers programs to reduce out-of-pocket costs for eligible patients.

Adakveo $25 Coupon

If you have private or commercial insurance, you may qualify for the Novartis Oncology Universal Co-pay Program. If eligible, you may pay only $25 per prescription, with coverage of up to $15,000 per year.

Eligible patients must have private, commercial insurance whose plan covers Adakveo. Once activated, present your copay card with your insurance card and prescription at a participating pharmacy or mail-order provider; reimbursement from other sources (like FSAs) is not allowed.

If you reach the $15,000 annual limit, you’ll be responsible for any remaining costs.

As always, we encourage users to stay updated on all offers by visiting our Adakveo coupon page.

Novartis Patient Assistance Foundation (NPAF)

If you’re uninsured, underinsured, or denied coverage, you may qualify for free medication through the Novartis Patient Assistance Foundation. This program is designed to support patients who cannot access their prescribed treatment through insurance alone.

How It Works:

  • Patients must submit a completed application, include proof of income (such as a recent tax return), and confirm U.S. residency
  • A healthcare provider must fill out a separate prescriber form and confirm that Adakveo is medically necessary
  • If approved, eligible patients receive their medication at no cost for a set period, with the option to reapply if treatment is ongoing

We encourage all users to check out our page on the NPAF, as it includes everything you need to know to apply to the program.

Final Thoughts

Adakveo offers real relief for people living with sickle cell disease, but its cost can be a significant barrier. Whether you have private insurance or no coverage at all, there are manufacturer programs that can help reduce or eliminate out-of-pocket costs.

If you’re unsure which programs you qualify for, NeedyMeds can help. Visit our website to explore our free tools and program listings, or call our Helpline at 800-503-6897 for personalized guidance.

About Me

Related Posts

About Us

Welcome to the NeedyMeds Voice! We look forward to presenting you with timely, provocative pieces on healthcare reform, patient advocacy, medication and healthcare access, and other health-related news. Our goals are to educate, enlighten, and elucidate; together, we will try to make sense of the myriad and ongoing healthcare-related changes in the U.S. today.